Clinical trial
Procalcitonin to Guide Antibiotic Stop in Neurocritical Care Patients. An Interventional Matched-cohort Study.
NCT03683693 is registered in ClinicalTrials.gov with General Hospital Groeninge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Procalcitonin to Guide Antibiotic Stop in Neurocritical Care Patients. An Interventional Matched-cohort Study.
- Lead sponsor
- General Hospital Groeninge
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 7, 2018
- Completion date
- September 30, 2020
- Enrollment
- 132 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.